Abstract:Stroke is a vascular disease in which brain cell death is initiated by a great reduction in blood flow. Only a few minutes of markedly lowered local blood flow (focal ischemia) may injure neurons and non-neuronal cells (e.g., endothelial cells and astrocytes) and lead to their death. Vasculogenesis is a process in which angioblasts differentiated into endothelial cells to form a primitive capillary network; whereas angiogenesis is the sprouting of capillaries from pre-existing blood vessels. Both mechanisms may contribute to neovascularization during embryogenesis and repair of damaged tissues in adults. The multi-potent embryonic stem (ES) cells can differentiate into neural cells and endothelial cells in vitro and in vivo. The multi-potentiality of ES cells provides a potential strategy for repairing the damaged brain after ischemic stroke. To examine the feasibility of ES cell transplantation in the ischemic brain and functional benefits of neovascularization, this study explored differentiations of transplanted ES cells in a rodent focal ischemia model. Transient focal cerebral ischemia was induced in adult male animals by 30-min occlusion of middle cerebral artery. Mouse ES cells were differentiated down neural lineages using the retinoic acid "4-/4+" protocol. To be able to identify ES cells after transplantation, ES cells were genetically marked with green fluorescent protein GFP or pre-labeled with BrdU and Hoechst. ES cell transplantation was performed 7 days after ischemia. Differentiation of ES cells was demonstrated by specific antibodies including MAP2, neurofilament, NeuN for neuron-like cells, GFAP for astrocytes, NG-2 for oligodendrocytes, Glut-1 and CD-31 for endothelial cells. Transplanted ES cells survived, differentiated and form functional structure in the ischemic core and penumbra regions. ES cell-derived endothelial cells formed new vesicular structures 7–14 days after transplantation. Local blood flow measured by Laser Doppler restored in the former ischemic region. Stroke animals received ES cell transplantation showed improved neurological and behavioral function 20–30 days after the transplantation. Our study demonstrates potential strategy of using ES cell transplantation to repair damaged brain tissues for reconstruction of neurovascular networks. The restoration of local blood supply and neuronal activities supports long-term functional benefits of ES cell transplantation after stroke (See Figure 1). Supported by NIH NS37373, NS45155, and AHA-Bugher Award 0170063N and 0170064N.

In Vivo Targeted MR Imaging of Endogenous Neural Stem Cells in Ischemic Stroke.

In Vivo Targeted Magnetic Resonance Imaging of Endogenous Neural Stem Cells in the Adult Rodent Brain

In Vivo Long-Term Tracking of Neural Stem Cells Transplanted into an Acute Ischemic Stroke Model with Reporter Gene-Based Bimodal MR and Optical Imaging

11 C-NMSP/ 18 F-FDG Micropet to Monitor Neural Stem Cell Transplantation in a Rat Model of Traumatic Brain Injury

Multimodality Molecular Imaging of Stem Cells Therapy for Stroke.

A Novel Polymeric Micelle Used for in Vivo MR Imaging Tracking of Neural Stem Cells in Acute Ischemic Stroke

In Vivo Monitoring of Neural Stem Cells after Transplantation in Acute Cerebral Infarction with Dual-Modal MR Imaging and Optical Imaging

Spatiotemporal Pet Imaging Of Dynamic Metabolic Changes After Therapeutic Approaches Of Induced Pluripotent Stem Cells, Neuronal Stem Cells, And A Chinese Patent Medicine In Stroke

In vivo Monitoring and Assessment of Exogenous Mesenchymal Stem Cell-Derived Exosomes in Mice with Ischemic Stroke by Molecular Imaging

Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke

Vasculogenesis, angiogenesis and local blood flow recovery after embryonic stem cells transplantation in the ischemic brain

MRI-Visible siRNA Nanomedicine Directing Neuronal Differentiation of Neural Stem Cells in Stroke

Upregulating HIF‐1α to boost the survival of neural stem cells via functional peptides‐complexed MRI‐visible nanomedicine for stroke therapy

Upregulating Microrna‐210 to Inhibit Apoptosis of Neural Stem Cells with an MRI–Visible Nanomedicine for Stroke Therapy

High MRI performance fluorescent mesoporous silica-coated magnetic nanoparticles for tracking neural progenitor cells in an ischemic mouse model.

Non-invasive Monitoring of Transplanted Endothelial Progenitor Cells in Diabetic Ischemic Stroke Models

High MR Sensitive Fluorescent Magnetite Nanocluster for Stem Cell Tracking in Ischemic Mouse Brain.

In Vivo MR Imaging of Intraarterially Delivered Magnetically Labeled Mesenchymal Stem Cells in a Canine Stroke Model

In vivo magnetic resonance imaging tracking of transplanted Feridex-labeled adult neural stem cells in rats

In vivo MRI of endogenous stem/progenitor cell migration from subventricular zone in normal and injured developing brains.

Stereotactically intracerebral transplantation of neural stem cells for ischemic stroke attenuated inflammatory responses and promoted neurogenesis: an experimental study with monkeys